Form 4: Glaukos Corp Executive Joseph E. Gilliam Reports Stock Transactions
SEC Form 4
Joseph E. Gilliam, President & COO of Glaukos Corporation, reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On April 3rd and 4th, 2024, Joseph E. Gilliam, the President & COO of Glaukos Corporation, executed transactions involving Glaukos Corp [GKOS] common stock.
- Gilliam exercised stock options to acquire 200 shares on each day at a price of $55.18 per share.
- Simultaneously, Gilliam sold 200 shares on each day at prices of $96.61 and $96.57 respectively.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2023.
- Following these transactions, Gilliam directly owns 101,845 shares of common stock and 43,196 stock options.
- The reported transactions also include 76,419 restricted stock units that have not yet vested.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy. There is no indication of unusual activity or concern.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Industry Context
Executive stock transactions are common and are often scrutinized by investors to gauge management's confidence in the company's future prospects. Rule 10b5-1 plans are designed to allow insiders to trade without being accused of acting on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to manage their stock holdings and avoid potential insider trading accusations.
- Comparing Gilliam's transactions to those of executives at similar companies like STAAR Surgical or Aerie Pharmaceuticals could provide further context.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares involved.
- The use of a Rule 10b5-1 plan provides transparency and reduces potential concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2022-03-24 | Date the stock option was granted by the Issuer. |
| 2023-03-07 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 2024-04-03 | Date of stock option exercise and sale of common stock. |
| 2024-04-04 | Date of stock option exercise and sale of common stock. |
| 2032-03-24 | Expiration date of the stock options. |
| 2024-04-05 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.